Bio2Vec

BIO-KNOWLEDGE-GRAPH

A knowledge graph of biological entities such as genes, gene functions, diseases, phenotypes and chemicals. Embeddings are generated with Walking RDF and OWL method.

Reduced alpha-2-antiplasmin activity

ID: HP:0040245

Type: http://bio2vec.net/ontology/phenotype

Label: Reduced alpha-2-antiplasmin activity

Synonyms: Reduced alpha-2-antiplasmin activity

Alternative IDs: als

API: GO

SPARQL: GO

Similar Entities

Reduced alpha-2-antiplasmin activity

HP:0040245
Reduced antithrombin antigen

HP:0040246
Prolonged Russell'\''s viper venom time

HP:0040244
Abnormality of circulating fibrinogen

HP:0011898
Reduced factor XIII activity

HP:0008357
Abnormality of the common coagulation pathway

HP:0010990
Factor X activation deficiency

HP:0008354
Hypofibrinogenemia

HP:0011900
Reduced euglobulin clot lysis time

HP:0040247
Increased plasma vitamin K epoxide after vitamin K supplementation

HP:0040239
Reduced factor VIII activity

HP:0003125
Prolonged euglobulin clot lysis time

HP:0040243
Hyperfibrinogenemia

HP:0011899
Abnormality of fibrinolysis

HP:0040224
Reduced prothrombin consumption

HP:0003337
Elevated factor V activity

HP:0011996
Reduced factor V activity

HP:0003225
Decreased level of tissue plasminogen activator

HP:0040230
Reduced plasminogen activator inhibitor 1 antigen

HP:0040249
Reduced factor X activity

HP:0008321
Reduced prothrombin antigen

HP:0040250
Abnormality of the intrinsic pathway

HP:0010989
Dysfibrinogenemia

HP:0011901
Reduced factor XII activity

HP:0004841
Abnormality of the coagulation cascade

HP:0003256
Abnormality of coagulation

HP:0001928
Prolonged prothrombin time

HP:0008151
Prolonged partial thromboplastin time

HP:0003645
Reduced antithrombin III activity

HP:0001976
Abnormality of prothrombin

HP:0012200
Hypercoagulability

HP:0100724
Abnormality of the extrinsic pathway

HP:0010988
Abnormality of von Willebrand factor

HP:0012146
Reduced kininogen activity

HP:0005527
Enhanced ristocetin cofactor assay activity

HP:0030136
Reduced prothrombin activity

HP:0012201
Decreased level of plasminogen

HP:0040228
Decreased level of histidine-rich glycoprotein

HP:0040227
Reduced factor VII activity

HP:0008169
Reduced factor XI activity

HP:0001929
Reduced von Willebrand factor activity

HP:0008330
Reduced factor IX activity

HP:0011858
Total absence von Willebrand factor multimers

HP:0030134
Hyperfibrinolysis

HP:0040236
Reduced plasminogen activator inhibitor 1 activity

HP:0040248
Impaired ristocetin cofactor assay activity

HP:0030129
Factor XIII subunit B deficiency

HP:0040234
Impaired binding of factor VIII to VWF

HP:0040237
Impaired ristocetin-induced platelet aggregation

HP:0011871
Factor XIII subunit A deficiency

HP:0040233
Absence of large von Willibrand factor multimers

HP:0030132
Decreased level of heparin co-factor II

HP:0040226
Reduced protein C activity

HP:0005543
Abnormality of the protein C anticoagulant pathway

HP:0030780
no_name

GO:0018804
Resistance to activated protein C

HP:0012175
Reduced quantity of Von Willebrand factor

HP:0012147
Abnormal umbilical stump bleeding

HP:0011884
Decreased level of thrombomodulin

HP:0040229
Prolonged whole-blood clotting time

HP:0005542
pulmonary vein morphogenesis

GO:0060577
Abnormal presence of ultra-large von Willebrand factor multimers

HP:0030133
regulation of telomeric loop formation

GO:1904418
Abnormality of the kinin-kallikrein system

HP:0005559
DCT cell fate commitment

GO:0072146
Impaired thrombin-induced platelet aggregation

HP:0011872
negative regulation by host of symbiont receptor-mediated signal transduction

GO:0075080
ductus venosus closure

GO:0061116
modulation by host of symbiont transmembrane receptor-mediated signal transduction

GO:0075081
Reduced protein S activity

HP:0004855
Mansonella perstans infectious disease

DOID:0050010
Abnormal von Willebrand factor multimer distribution

HP:0030131
cellooligosaccharide metabolic process

GO:2000902
Impaired von Willibrand factor collagen binding activity

HP:0030130
monocular exotropia with A pattern

DOID:11854
pentastarch

http://aber-owl.net/drug/CID116213095
modulation by host of symbiont signal transduction mediated by G-protein beta subunit

GO:0075093
positive regulation of protein polyubiquitination

GO:1902916
obsolete nebulin binding

GO:0051419
Elevated creatine kinase after exercise

HP:0008331
modulation by symbiont of host signal transduction mediated by G-protein gamma subunit

GO:0075127
mitochondrial double-strand break repair

GO:0097551
cellooligosaccharide catabolic process

GO:2000903
MAP kinase activity involved in cell wall organization or biogenesis

GO:0038067
Impaired arachidonic acid-induced platelet aggregation

HP:0011870
pyridoxamine-oxaloacetate transaminase activity

GO:0019162
positive regulation of protein K48-linked ubiquitination

GO:1902524
cyclodextrin metabolic process

GO:2000900
regulation of octopamine signaling pathway

GO:2000128
obsolete growth or development of symbiont in host vascular tissue

GO:0075068
mitochondrial lrRNA export from mitochondrion

GO:0019091
H2B histone acetyltransferase activity

GO:0044013
Golgi trans cisterna membrane

GO:1990676
hypotonic response

GO:0006971
Increased urinary potassium

HP:0003081
NADH kinase activity

GO:0042736
positive regulation of octopamine signaling pathway

GO:2000130
regulation of tyramine signaling pathway

GO:2000131
negative regulation by host of symbiont transmembrane receptor-mediated signal transduction

GO:0075083
Anal canal squamous cell carcinoma

HP:0030438

Neighbourhood Visualization